Identification of resident hepatic stem cell populations
Nicholas A Shackel, Fiona J Warner – 28 November 2007
The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation
Jennifer T. Wells, Adnan Said, Rashmi Agni, Santiago Tome, Sarah Hughes, Parul Dureja, Michael R. Lucey – 28 November 2007 – Patients with clinical acute alcoholic hepatitis (AAH) are not considered suitable candidates for orthotopic liver transplantation (OLT). The histological correlates of AAH are often seen in the explanted liver at the time of transplantation. The importance of these findings remains inconclusive regarding their role as a prognostic marker for patient or allograft health.
Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers
Ragai R. Mitry, Ruth De Bruyne, Alberto Quaglia, Robin D. Hughes, Anil Dhawan – 28 November 2007
Seventy‐two weeks of peginterferon and ribavirin for patients with partial early virologic response?
John C. Hoefs, Timothy R. Morgan – 28 November 2007
Therapy with vasoconstrictor drugs in cirrhosis: The time has arrived
Pere Ginès, Mónica Guevara – 28 November 2007
Modified outflow reconstruction with a venous patch in domino liver transplantation
Matteo Cescon, Gian Luca Grazi, Matteo Ravaioli, Alessandro Cucchetti, Giorgio Ercolani, Antonio Daniele Pinna – 28 November 2007
Surgical stress and tumor behavior: Impact of ischemia‐reperfusion and hepatic resection on tumor progression
Michitaka Ozaki, Satoru Todo – 28 November 2007
Liver and partial atrium transplantation for chronic Budd‐Chiari syndrome
Matteo Ravaioli, Matteo Cescon, Elisa Mikus, Gian Luca Grazi, Giorgio Ercolani, Takuya Kimura, Francesco Tuci, Piero Maria Mikus, Mauro Bernardi, Antonio Daniele Pinna – 28 November 2007
Gut‐derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin‐6/signal transducer and activator of transcription 3 activity
John G. Lunz, Susan M. Specht, Noriko Murase, Kumiko Isse, Anthony J. Demetris – 28 November 2007 – Intraorgan dendritic cells (DCs) monitor the environment and help translate triggers of innate immunity into adaptive immune responses. Liver‐based DCs are continually exposed, via gut‐derived portal venous blood, to potential antigens and bacterial products that can trigger innate immunity. However, somehow the liver avoids a state of perpetual inflammation and protects central immune organs from overstimulation.
Pegylated interferon alpha‐2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
Sanaa M. Kamal, Samer S. El Kamary, Michelle D. Shardell, Mohamed Hashem, Imad N. Ahmed, Mohamed Muhammadi, Khalifa Sayed, Ashraf Moustafa, Sarah Abdel Hakem, Amany Ibrahiem, Mohamed Moniem, Hoda Mansour, Mohamed Abdelaziz – 28 November 2007 – In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined.